Pharmaceuticals Russia

Russia Bacteriophage Therapy Market Analysis, 2024–2034

Russia Bacteriophage Therapy Market Industry Trends and Forecast to 2034: Segmented by (Type, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Russia · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $0.7 Mn Estimated value
Estimate 2025 $0.8 Mn 1% of the global market
Projected 2034 $2.8 Mn 257.3% Adds $2.0 Mn over 9 forecast years
CAGR 2025–2034 15.2% Faster than 76% of 160 Pharmaceuticals markets here
Key players 5 Companies profiled
  • Russia is 1% of the global market.
  • In Europe, the largest is Germany at $2.9 Mn.
  • Fastest growing: Russia (this report) at 15.2% a year.
  • Russia ranks 6th of 6 by size in Europe.

Market size projection

Russia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$2.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Bacteriophage Therapy Market market size by year, Russia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $0.7 Mn — —
2025 (base) $0.8 Mn +$0.1 Mn —
2026 (forecast) $0.9 Mn +$0.1 Mn +15.2%
2027 (forecast) $1.1 Mn +$0.1 Mn +32.7%
2028 (forecast) $1.2 Mn +$0.2 Mn +52.9%
2029 (forecast) $1.4 Mn +$0.2 Mn +76.1%
2030 (forecast) $1.6 Mn +$0.2 Mn +102.9%
2031 (forecast) $1.9 Mn +$0.2 Mn +133.7%
2032 (forecast) $2.1 Mn +$0.3 Mn +169.3%
2033 (forecast) $2.5 Mn +$0.3 Mn +210.2%
2034 (forecast) $2.8 Mn +$0.4 Mn +257.3%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $79.4 Mn
  2. North America $40.1 Mn
  3. US $30.2 Mn
  4. APAC $18.6 Mn
  5. Europe $14.9 Mn
  6. China $6.5 Mn
  7. Canada $6.2 Mn
  8. Japan $4.6 Mn
  9. Middle East $3.6 Mn
  10. Latin America $3.5 Mn
  11. Germany $2.9 Mn
  12. UK $2.2 Mn
  13. Brazil $2.1 Mn
  14. France $2.1 Mn
  15. Italy $1.7 Mn
  16. Ecuador $1.6 Mn
  17. India $1.5 Mn
  18. Saudi Arabia $1.4 Mn
  19. Spain $1.3 Mn
  20. Africa $1.2 Mn
  21. Mexico $1.2 Mn
  22. Australia $0.9 Mn
  23. New Zealand $0.8 Mn
  24. Russia (this report) $0.8 Mn
  25. South Africa $0.5 Mn
  26. UAE $0.4 Mn
  27. Egypt $0.1 Mn
  28. Hong Kong $0.1 Mn
  29. Malaysia $0.1 Mn
  30. Philippines $0.1 Mn
  31. Singapore $0.1 Mn
  32. Thailand $0.1 Mn
  33. Kenya $0.0 Mn

The Russia Bacteriophage Therapy Market Analysis Executive Summary

Bacteriophage therapy uses viruses that infect only bacteria to treat infections that antibiotics cannot clear.

Key segments of the bacteriophage Therapy market include type (Natural Phages, Engineered Phages and Phage Cocktails) and application (Chronic Wounds, Respiratory Infections and Urinary Infections).

Russia Bacteriophage Therapy Market Dynamics

Market Growth Drivers

Rising antimicrobial resistance, outbreaks of new and returning diseases, climate change spreading infections and strong global funding for prevention are driving the bacteriophage Therapy market.

Opportunity

New vaccines, rapid tests and public-private funding for neglected diseases give the bacteriophage Therapy market room to grow, especially in Asia, Africa and Latin America.

Market Restraints

Low prices in poorer markets, weak returns for new antibiotics, vaccine hesitancy and cold-chain problems hold back the bacteriophage Therapy market.

Competitive Landscape for Bacteriophage Therapy Market in Russia

The bacteriophage Therapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Bacteriophage Therapy Market in Russia

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for bacteriophage Therapy. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Russia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Bacteriophage Therapy right now, from free public sources.

Latest research 957 papers since 2021 (worldwide)

  1. Bacteriophage associated liver injury in a person with cystic fibrosis and prior liver transplantation. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2026
  2. Prophylactic Post-lung Transplant Bacteriophage Therapy Against XDR Pseudomonas aeruginosa in Cystic Fibrosis: A Case Report. Infection, 2026
  3. Receptor-Targeted Sequential Phage Dosing against Pseudomonas aeruginosa PAO1: An In Vitro Proof-of-Concept Study. Pharmaceutical research, 2026
  4. Antibiotics and antibiotic resistance race: a chronicle of antibiotic discovery against Gram-negative bacteria during 2001-2020: way forward. Iranian journal of microbiology, 2026
  5. HydroGuard: a controlled release hydrogel-phage delivery system to combat catheter-associated urinary tract infections. Frontiers in systems biology, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Bacteriophage Therapy in context

Russia compared

  • Health spending per person: 1,003 US$ per person (2023). World: 1,317 US$ per person (2023). 6th highest of the 6 countries we cover in Europe.[1]
  • Doctors: 5.11 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 6 countries we cover in Europe.[2]
  • People aged 65 and over: 17.8% of people (2025). World: 10.4% of people (2025). 6th highest of the 6 countries we cover in Europe.[3]

Questions, answered with public data

How many clinical trials on Bacteriophage Therapy are running in Russia?
1 study is recruiting, active or about to start in Russia.[4]
How much research is published on Bacteriophage Therapy?
PubMed lists 957 papers added since January 2021 that match this market, worldwide.[5]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Russia. Retrieved 12 Nov 2026.

[5] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Bacteriophage Therapy in Russia? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Molecular Point-of-Care Tests: Lab Accuracy, Clinic SpeedTB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade… Antimicrobial Resistance: Why Faster Testing MattersDrug-resistant infections already kill over a million people a year. Faster testing helps doctors pick the… Needleless Connectors: Small Device, Big Infection ImpactNeedleless connectors protect staff from needle injuries, but if not cleaned they can let germs into the…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Russia

See all
Same topic, other categories

Related on antibiotics and infectious diseases

See the topic